Organon & Co Ordinary Shares (OGN)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

$6.83

Buy

$6.84

arrow-down$-0.185 (-2.64%)

Prices updated at 16 Dec 2025, 15:24 EST

Prices minimum 15 mins delay

Prices in USD

S&P 500

-0.15%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	6,263m	6,403m
	3,748m	3,715m
	1,327m	1,486m
	21.19	23.21
	1,023m	864m
	1,436m	1,604m
Sales, General and administrative	1,893m	1,760m
Interest expenses	527m	520m
Provision for income taxes	-350m	-57m
Operating expenses	2,421m	2,229m
Income before taxes	673m	807m
Net income available to common shareholders	1,023m	864m
	4.01	3.36
Net interest income	-527m	-520m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	3.99	3.33
Free cash flow per share	1.6564	2.5007
Book value/share	-2.3041	1.9123
Debt equity ratio	-	18.771186

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	4,508m	4,348m
Current liabilities	2,918m	2,718m
Total capital	8,681m	9,332m
Total debt	8,760m	8,880m
Total equity	-70m	472m
Total non current liabilities	-	-
Loans	8,751m	8,860m
Total assets	12,058m	13,101m
Total liabilities	-	-
Cash and cash equivalents	693m	675m
Common stock	256m	258m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	706m	693m
Cash dividends paid	-294m	-297m
	538m	588m
Investments (gains) losses	-260m	-513m
	693m	675m
Net income	-	-
	799m	939m
	-261m	-351m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.